Back | Next |
home / stock / pali / pali message board
Subject | By | Source | When |
---|---|---|---|
15 | peterus | investorshub | 03/31/2023 7:25:50 PM |
5 or 50? | IOUBLOKE1 | investorshub | 03/31/2023 7:25:09 PM |
3.58s back 3.40s shortie is stronge | peterus | investorshub | 03/31/2023 6:28:31 PM |
going to fly ..... watch out shorts need | peterus | investorshub | 03/31/2023 5:43:31 PM |
BOUGHT AT 2.23 SOLD AT 3.42 | WHIP THE HORSE | investorshub | 03/31/2023 4:30:04 PM |
cash on hand mid 2024 phase2 data Q2 | peterus | investorshub | 03/31/2023 3:31:45 PM |
bought in 3.10s could see a nice runner | peterus | investorshub | 03/31/2023 3:29:24 PM |
Here we go! | Jess070283 | investorshub | 03/31/2023 3:06:52 PM |
it's now 3.46 in the premarket . Once | podacs | investorshub | 03/31/2023 12:06:07 PM |
$PALI ------- $2.99 after hours. Tomorrow | WHIP THE HORSE | investorshub | 03/30/2023 8:41:35 PM |
better get some before the rest of the | podacs | investorshub | 03/30/2023 7:50:30 PM |
PALI $2.62 A BEAST IS BORN | WHIP THE HORSE | investorshub | 03/30/2023 6:36:58 PM |
PALI $.251 NOW, UP 48% | WHIP THE HORSE | investorshub | 03/30/2023 6:05:54 PM |
$PALI moving nicely, target $50 by MAXIM GROUP | WHIP THE HORSE | investorshub | 03/30/2023 6:04:46 PM |
Maxim Group $50 price target. This one best | podacs | investorshub | 03/30/2023 3:25:07 PM |
$PALI target announced to $50 by Maxim Group | WHIP THE HORSE | investorshub | 03/30/2023 3:24:44 PM |
$PALI a monster in the making.!!!!! | WHIP THE HORSE | investorshub | 03/30/2023 2:37:59 PM |
PALI HI https://www.benzinga.com/news/23/03/31583007/maxim-group-upgrades-palisade-bio-to-buy-announ | TheFinalCD | investorshub | 03/30/2023 1:51:55 PM |
Can you tell me what you think about | traderbbc1 | investorshub | 02/07/2023 1:23:11 AM |
znewcar1: $PALI 29% v9,587M c2.90 f2,018M H3.55 ML2.11 RL2.22 | znewcar1 | investorshangout | 01/31/2023 11:02:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Palisade Bio Inc. Company Name:
PALI Stock Symbol:
NASDAQ Market:
PALI-2108 is orally delivered and colon-specific allowing for local activity with low systemic exposure Company on track to commence Phase 1 human clinical study of PALI-2108 for the treatment of UC before year end Carlsbad, CA, June 11, 2024 (GLOBE NEWSWIRE) -- Palisad...
Live video webcast on Monday, June 17 th at 12:00 PM ET Carlsbad, CA, June 10, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel t...
2024-05-26 23:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...